Enterprise Value
$159.74 M
-$5.02 M-3.05%
Fri, 07 Feb 2025 21:02:02 GMT
Summary
- As of February 8, 2025, GALT enterprise value is $159.74 million, with a fall of -$5.02 million (-3.05%) during the most recent trading day.
- Over the past year, GALT enterprise value has increased by +$14.03 million (+9.63%).
- GALT enterprise value is now -53.25% below its all-time high of $341.72 million.
Performance
GALT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
GALT Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -3.0% | -5.8% | -5.8% |
| 1 m1 month | +2.0% | +4.0% | +4.0% |
| 3 m3 months | -38.1% | -54.5% | -54.8% |
| 6 m6 months | -19.6% | -37.1% | -37.6% |
| ytdytd | +0.8% | +1.6% | +1.6% |
| 1 y1 year | +9.6% | -17.4% | -18.6% |
| 5 y5 years | +65.5% | -42.9% | -48.2% |
GALT Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.0% | $147 M | +9.0% | |
| 3 m | 3-month | $271 M | -41.0% | $130 M | +23.3% |
| 6 m | 6-month | $271 M | -41.0% | $130 M | +23.3% |
| 1 y | 1-year | $321 M | -50.3% | $130 M | +23.3% |
| 3 y | 3-year | $321 M | -50.3% | $68 M | +133.7% |
| 5 y | 5-year | $321 M | -50.3% | $39 M | +313.0% |
| alltime | all time | $342 M | -53.3% | -$1 M | >+9999.0% |
Galectin Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $159.74 M(+0.8%) |
| 2024 | $158.49 M(+6.5%) |
| 2023 | $148.80 M(+68.3%) |
| 2022 | $88.43 M(-21.2%) |
| 2021 | $112.24 M(+11.4%) |
| 2020 | $100.75 M(-12.6%) |
| 2019 | $115.28 M(-13.3%) |
| 2018 | $133.03 M(+14.2%) |
| 2017 | $116.48 M(+589.6%) |
| 2016 | $16.89 M(-21.2%) |
| 2015 | $21.43 M(-55.5%) |
| 2014 | $48.17 M(-65.1%) |
| Date | Value |
|---|---|
| 2013 | $138.08 M(+486.0%) |
| 2012 | $23.56 M(-65.4%) |
| 2011 | $68.02 M(+31.8%) |
| 2010 | $51.63 M(+262.6%) |
| 2009 | $14.24 M(+239.2%) |
| 2008 | $4.20 M(-84.4%) |
| 2007 | $26.94 M(+94.3%) |
| 2006 | $13.86 M(-82.4%) |
| 2005 | $78.85 M(+36.9%) |
| 2004 | $57.59 M(-34.2%) |
| 2003 | $87.50 M(+64.2%) |
| 2002 | $53.29 M |
FAQ
- What is Galectin Therapeutics enterprise value?
- What is the all time high enterprise value for Galectin Therapeutics?
- What is GALT enterprise value year-to-date change?
- What is Galectin Therapeutics enterprise value year-on-year change?
What is Galectin Therapeutics enterprise value?
The current enterprise value of GALT is $159.74 M
What is the all time high enterprise value for Galectin Therapeutics?
Galectin Therapeutics all-time high enterprise value is $341.72 M
What is GALT enterprise value year-to-date change?
Galectin Therapeutics enterprise value has changed by +$1.26 M (+0.79%) since the beginning of the year
What is Galectin Therapeutics enterprise value year-on-year change?
Over the past year, GALT enterprise value has changed by +$14.03 M (+9.63%)